Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
People with type 2 diabetes often struggle with both blood sugar control and excess weight—challenges that frequently reinforce each other. Semaglutide, a GLP-1 receptor agonist, addresses both issues by helping regulate blood glucose while reducing hunger signals in the brain. This dual mechanism has made it a significant option for diabetic patients pursuing meaningful weight loss.
How Semaglutide Works for Weight Loss in Diabetics
Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone your body produces naturally to manage blood sugar and appetite. When you inject or take oral semaglutide, it activates GLP-1 receptors in your brain and pancreas, slowing stomach emptying and increasing feelings of fullness. For diabetics, this mechanism serves double duty: improved glucose control happens alongside reduced calorie intake, creating conditions for sustainable weight loss.
Clinical trials have demonstrated that semaglutide users experience average weight reductions of 5-15% of body weight over 12-16 weeks, depending on dosage and individual response. People with type 2 diabetes often see additional benefits including lower A1C levels (a measure of long-term blood sugar control) and improved cardiovascular markers. These improvements frequently persist when patients remain consistent with treatment.
Weight Loss Results for Diabetic Patients on Semaglutide
The SUSTAIN trials, a series of long-term studies, showed that diabetic patients using semaglutide achieved significant reductions in body weight compared to placebo and some other diabetes medications. Participants also experienced improvements in kidney function and reduced rates of cardiovascular events—meaningful outcomes beyond the scale. Individual results vary based on starting weight, adherence, lifestyle changes, and genetic factors that influence how your body processes GLP-1 signals.
Weight loss typically becomes noticeable within 2-4 weeks as appetite suppression develops, though maximum results usually emerge over 3-6 months. Many diabetic patients report feeling more satisfied with smaller portions and experiencing fewer intense cravings. This behavioral shift, combined with improved blood sugar stability, often makes maintaining weight loss easier than with diet alone.
Important Considerations Before Starting Semaglutide
Semaglutide is not appropriate for everyone. Patients with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2) should avoid it. Additionally, people taking certain diabetes medications—especially insulin or other GLP-1 drugs—may need dosage adjustments to prevent dangerously low blood sugar. Discussing your complete medication list and medical history with your healthcare provider is essential before beginning treatment.
Common side effects include nausea, vomiting, constipation, and loss of appetite (which is actually the intended effect at higher doses). Most side effects are mild and improve as your body adjusts over 1-2 weeks. Some patients experience muscle loss alongside fat loss, making strength training and adequate protein intake important during your weight loss journey.
Personalized Semaglutide Treatment Through Genetic Insights
PlexusDx offers compounded semaglutide injections starting at $149 per month from licensed 503A compounding pharmacies, with no insurance requirement and HSA/FSA eligibility. Your dose may need to go up as your body adapts—your price won't. The Precision Peptide Genetic Test (available for $99 after your first month) maps 14 metabolic pathways and 150+ genetic insights, including variants in the GLP1R gene that predict how effectively your body will respond to semaglutide.
Understanding your genetic predispositions for peptide sensitivity helps PlexusDx recommend whether semaglutide alone, combined therapies like GLP-Squared (semaglutide plus tirzepatide), or oral formulations better match your body's biochemistry. This personalization increases the likelihood of meaningful weight loss while minimizing unnecessary trial-and-error dosing. PlexusDx serves all 50 states with no membership fees, making access straightforward for diabetics seeking weight loss support.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can semaglutide help me lose weight if I have type 2 diabetes?
Yes, semaglutide effectively supports weight loss in diabetic patients by improving blood sugar control and reducing hunger. Most people see noticeable results within 2-4 weeks, with greater weight loss (5-15% of body weight) emerging over 3-6 months. Your healthcare provider can determine if semaglutide is appropriate for your specific diabetes profile and current medications.
What do clinical trials show about semaglutide for diabetic weight loss?
The SUSTAIN trials demonstrated that semaglutide users achieved significant weight loss, improved A1C levels, and better cardiovascular markers compared to placebo. Patients with type 2 diabetes experienced average weight reductions of 5-15% depending on dosage, with benefits often sustained long-term through consistent treatment.
How much does semaglutide cost through PlexusDx?
PlexusDx compounded semaglutide injections start at $149 per month from licensed 503A pharmacies, with no insurance requirement, membership fees, or price increases if your dose increases. The medication is HSA/FSA eligible, and PlexusDx serves all 50 states.
Are there side effects I should know about before starting semaglutide?
Common side effects include nausea, vomiting, constipation, and decreased appetite—with most improving within 1-2 weeks as your body adjusts. More serious considerations include avoiding semaglutide if you have medullary thyroid cancer history or MEN2 syndrome, and coordinating dosages carefully if you take insulin or other GLP-1 drugs.
How does the PlexusDx Precision Peptide Genetic Test help with semaglutide treatment?
The $99 test (available after your first month) analyzes 14 metabolic pathways including the GLP1R gene variant rs6923761, which predicts how efficiently your body responds to semaglutide. This genetic insight helps PlexusDx recommend optimal dosing and whether combination therapies might work better for your biochemistry.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Frequently Do You Take Ozempic®? Navigating Your Weekly Dosing Schedule
How Fast Does Ozempic Work After Injection?